Skip to content

Translational Development Acquisition Corp.

TDAC· NasdaqCore metricsCIK 1926599

Blank check companies306 peers

Last sale
Nov 10, 2026
Market cap
$209.50M
19.31M shares
Filings
84
—
—
—
-$9.29M
Q3 2026N/M FY25 yoy
-$548.41K
Q3 2026N/M FY25 yoy
—
—
—
—
—
—
$85.85K
Q3 2026−93.2% FY25 yoy
$209.50M
32.9×
—
—
—
—

FY2025 figures · derived

Price

$10.85+4.23%+$0.44past year
Nov 10, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

General And Administrative

$944.54KFY 2025
$944.54K0FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$944,538reported
FY 20242024-12-31$196,358reported

Blank check companies

Translational Development Acquisition Corp. is the 170th largest of the 307 covered companies the SEC files under this code, by market cap. SIC 6770

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Translational Development Acquisition Corp. · CIK 1926599 · Engraved from SEC EDGAR